Novel Benzylamine Derivatives: Synthesis, Anti-Mycobacterium Tuberculosis Evaluation and Predicted ADMET Properties
Authors:
- Mmaserole R. SedibanaMSMmaserole R. Sedibana
- Tlabo C. LebohoTLTlabo C. Leboho
Open Access
- 31 March 2023
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in The Open Medicinal Chemistry Journal
- Vol. 17 (1)
Abstract
Background: Tuberculosis (TB), a disease caused by the bacillus bacteria Mycobacterium tuberculosis is one of the major contributors of ill health in the world. TB is ranked in the top 10 causes of death globally and it is the leading killer associated with a single infectious agent. According to the World Health Organization (WHO), global number of deaths associated with TB have been slowly declining with 1.3 million in reported 2016 and 2017, and 1.2 million reported in 2018 and 2019. Objective: The synthesis, characterisation, biological evaluations, and the prediction of ADMET properties of the novel benzylamine derivatives. Methods: Commercially available reagents and solvents were purchased from Sigma Aldrich and Merck (South Africa). All chemicals were used as received, unless otherwise stated. The synthesised crude compounds were purified by flash silica gel column chromatography (5 – 30% ethyl acetate in hexane). The successful formation and purity of the synthesised compounds was confirmed by NMR, HRMS and melting point. Results: The respective organic compounds were synthesised by treating 3-ethoxysalcyladehyde, 5-bromo-3-ethoxysalcyladehyde, 5-chloro-3-ethoxysalcyladehyde with various aromatic amines and the products were obtained in good to excellent yields. The 1H and 13C NMR spectra of all the products showed the appearance of the methylene signals ranging from 3.88 – 4.68 ppm and 42.25 – 52.57 ppm respectively. Additionally, most compounds showed anti-Mycobacterium tuberculosis activity that ranged between 20 and 28 µM. Conclusion: A total of 36 compounds were synthesised and successfully biologically evaluated against Mycobacterium tuberculosis (Mtb) H37RV strain. All compounds showed activity against Mtb at concentrations of > 20 µM < 28 µM with the exception of compound one that was active against Mtb at higher concentration (MIC90 > 125 µM).Keywords
This publication has 34 references indexed in Scilit:
- Living with the challenges of treating tuberculosisBreathe, 2015
- Synthesis Characterization and Antibacterial, Antifungal Activity of N-(Benzyl Carbamoyl or Carbamothioyl)-2-hydroxy Substituted Benzamide and 2-Benzyl Amino-Substituted BenzoxazinesInternational Journal of Medicinal Chemistry, 2013
- Challenges to the global control of tuberculosisRespirology, 2013
- Synthesis and structure–activity relationship of benzylamine supported platinum(iv) complexesNew Journal of Chemistry, 2013
- Synthesis and biological evaluation of new 13-n-nonylprotoberberine derivatives as antitubercular agentsActa Pharmaceutica Sinica B, 2013
- Challenges in the development of drugs for the treatment of tuberculosisThe Brazilian Journal of Infectious Diseases, 2013
- Synthesis of arylbromides from arenes and N -bromosuccinimide (NBS) in acetonitrile — A convenient method for aromatic brominationCanadian Journal of Chemistry, 2009
- Reductive Aminations of Carbonyl Compounds with Borohydride and Borane Reducing Agents2002
- Benzylamines: synthesis and evaluation of antimycobacterial propertiesJournal of Medicinal Chemistry, 1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983